These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 25131292

  • 1. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation.
    Komeda T, Ishii S, Itoh Y, Ariyasu Y, Sanekata M, Yoshikawa T, Shimada J.
    J Infect Chemother; 2014 Nov; 20(11):689-95. PubMed ID: 25131292
    [Abstract] [Full Text] [Related]

  • 2. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation.
    Komeda T, Ishii S, Itoh Y, Ariyasu Y, Sanekata M, Yoshikawa T, Shimada J.
    J Infect Chemother; 2015 Mar; 21(3):194-201. PubMed ID: 25523716
    [Abstract] [Full Text] [Related]

  • 3. Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors.
    Komeda T, Ishii S, Itoh Y, Sanekata M, Yoshikawa T, Shimada J.
    J Infect Chemother; 2016 Oct; 22(10):677-84. PubMed ID: 27497712
    [Abstract] [Full Text] [Related]

  • 4. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE, Gabay MP, Steinke LM, Vanosdol SJ.
    Ann Pharmacother; 2010 Oct; 44(7-8):1240-9. PubMed ID: 20516360
    [Abstract] [Full Text] [Related]

  • 5. Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data.
    Choi WS, Ryu SY, Lee J, Hong SB, Eom JS, Shin J, Park KH, Ohk T, Chung JW, Chung DR, Kim DK, Lee SR, Kim PY, Kim SW, Noh JY, Song JY, Cheong HJ, Kim WJ.
    J Korean Med Sci; 2018 Aug 06; 33(32):e212. PubMed ID: 30079005
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.
    Barroso L, Treanor J, Gubareva L, Hayden FG.
    Antivir Ther; 2005 Aug 06; 10(8):901-10. PubMed ID: 16430195
    [Abstract] [Full Text] [Related]

  • 7. Peramivir use for treatment of hospitalized patients with influenza A(H1N1)pdm09 under emergency use authorization, October 2009-June 2010.
    Yu Y, Garg S, Yu PA, Kim HJ, Patel A, Merlin T, Redd S, Uyeki TM.
    Clin Infect Dis; 2012 Jul 06; 55(1):8-15. PubMed ID: 22491506
    [Abstract] [Full Text] [Related]

  • 8. Intravenous peramivir for treatment of influenza in hospitalized patients.
    Ison MG, Fraiz J, Heller B, Jauregui L, Mills G, O'Riordan W, O'Neil B, Playford EG, Rolf JD, Sada-Diaz E, Elder J, Collis P, Hernandez JE, Sheridan WP.
    Antivir Ther; 2014 Jul 06; 19(4):349-61. PubMed ID: 23985625
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Peramivir: A Review in Uncomplicated Influenza.
    Scott LJ.
    Drugs; 2018 Sep 06; 78(13):1363-1370. PubMed ID: 30196350
    [Abstract] [Full Text] [Related]

  • 11. Peramivir: an intravenous neuraminidase inhibitor.
    McLaughlin MM, Skoglund EW, Ison MG.
    Expert Opin Pharmacother; 2015 Sep 06; 16(12):1889-900. PubMed ID: 26153242
    [Abstract] [Full Text] [Related]

  • 12. Peramivir for the treatment of influenza.
    Shetty AK, Peek LA.
    Expert Rev Anti Infect Ther; 2012 Feb 06; 10(2):123-43. PubMed ID: 22339187
    [Abstract] [Full Text] [Related]

  • 13. A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment.
    Chen JY, Wei SK, Lai CC, Weng TS, Wang HH.
    Medicina (Kaunas); 2020 Feb 05; 56(2):. PubMed ID: 32033501
    [Abstract] [Full Text] [Related]

  • 14. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir.
    Arya V, Carter WW, Robertson SM.
    Clin Pharmacol Ther; 2010 Nov 05; 88(5):587-9. PubMed ID: 20959843
    [Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.
    Yoshino Y, Seo K, Koga I, Kitazawa T, Ota Y.
    Clin Respir J; 2015 Apr 05; 9(2):228-32. PubMed ID: 24612842
    [Abstract] [Full Text] [Related]

  • 16. Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials.
    Whitley R, Laughlin A, Carson S, Mitha E, Tellier G, Stich M, Elder J, Alexander WJ, Dobo S, Collis P, Sheridan WP.
    Antivir Ther; 2015 Apr 05; 20(7):709-19. PubMed ID: 25318121
    [Abstract] [Full Text] [Related]

  • 17. Clinical effects of oseltamivir, zanamivir, laninamivir and peramivir on seasonal influenza infection in outpatients in Japan during the winter of 2012-2013.
    Takemoto Y, Asai T, Ikezoe I, Yano T, Ichikawa M, Miyagawa S, Matsumoto J.
    Chemotherapy; 2013 Apr 05; 59(5):373-8. PubMed ID: 24821568
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of peramivir for influenza treatment.
    Hata A, Akashi-Ueda R, Takamatsu K, Matsumura T.
    Drug Des Devel Ther; 2014 Apr 05; 8():2017-38. PubMed ID: 25368514
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease.
    Takamatsu K, Marumo S, Fukui M, Hata A.
    J Microbiol Immunol Infect; 2017 Aug 05; 50(4):541-544. PubMed ID: 28720319
    [Abstract] [Full Text] [Related]

  • 20. Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance.
    Kashiwagi S, Yoshida S, Yamaguchi H, Niwa S, Mitsui N, Tanigawa M, Shiosakai K, Yamanouchi N, Shiozawa T, Yamaguchi F.
    Int J Antimicrob Agents; 2012 Nov 05; 40(5):381-8. PubMed ID: 22871369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.